4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-18-005841
10% owner bought 265,000 shares at $17.00 ($4,505,000)
- 10% owner acquired 1,196,552 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
venBio Global Strategic Fund II L.P. · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-01-25 | Purchase : show line 1 in the form | +265,000 | $17.00 | $4,505,000 | 265,000 | D |
| 2018-01-29 | Conversion : show line 2 in the form | +1,196,552 | 1,461,552 | D | ||
| Open-market purchases · 265,000 sh · avg $17.00 · $4,505,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2018-01-29 | Conversion : show line 3 in the form Series C Preferred Stock | −3,227,700 | 1,196,552 | 0 | D |
Loading xslF345X03/doc4.xml…